Dianthus Therapeutics Inc.(DNTH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DNTH Dianthus Therapeutics Inc.

休市中 07-11 16:00:00 EDT

20.06

-0.55

-2.67%

盘后20.06

+0.000.00%

16:46 EDT

最高20.80	最低19.76	成交量28.35万
今开20.49	昨收20.61	日振幅5.05%
总市值6.45亿	流通市值2.20亿	总股本3,216万
成交额570.20万	换手率2.58%	流通股本1,099万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DNTH","market":"US","secType":"STK","nameCN":"Dianthus Therapeutics Inc.","latestPrice":20.06,"timestamp":1752264000000,"preClose":20.61,"halted":0,"volume":283453,"hourTrading":{"tag":"盘后","latestPrice":20.06,"preClose":20.06,"latestTime":"16:46 EDT","volume":6184,"amount":124052.4,"timestamp":1752266814775},"delay":0,"floatShares":10988522,"shares":32159982,"eps":-2.810198,"marketStatus":"休市中","change":-0.55,"latestTime":"07-11 16:00:00 EDT","open":20.49,"high":20.8,"low":19.76,"amount":5701991.56954,"amplitude":0.050461,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.810198,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":20.61,"preHourTrading":{"tag":"盘前","latestPrice":21.11,"preClose":20.61,"latestTime":"09:29 EDT","volume":4291,"amount":89871.442052,"timestamp":1752240550383},"postHourTrading":{"tag":"盘后","latestPrice":20.06,"preClose":20.06,"latestTime":"16:46 EDT","volume":6184,"amount":124052.4,"timestamp":1752266814775},"volumeRatio":0.5502493678976682,"impliedVol":0.2596,"impliedVolPercentile":0.064},"requestUrl":"/m/hq/s/DNTH","defaultTab":"news","newsList":[{"id":"2550213906","title":"Dianthus Therapeutics, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550213906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550213906?lang=zh_cn&edition=full","pubTime":"2025-07-10 22:29","pubTimestamp":1752157768,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日22时29分，Dianthus Therapeutics, Inc.股票出现波动，股价大幅下跌5.12%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710222928953d8fa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710222928953d8fa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","DNTH","LENZ"],"gpt_icon":0},{"id":"2549245554","title":"Dianthus Therapeutics, Inc.盘中异动 大幅下跌5.04%报17.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549245554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549245554?lang=zh_cn&edition=full","pubTime":"2025-07-08 02:21","pubTimestamp":1751912515,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日02时21分，Dianthus Therapeutics, Inc.股票出现异动，股价大幅下跌5.04%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507080221569539d6d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507080221569539d6d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","BK4539","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2543954251","title":"Dianthus Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.41%报19.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543954251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543954251?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:44","pubTimestamp":1749757451,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日03时44分，Dianthus Therapeutics, Inc.股票出现异动，股价急速拉升5.41%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613034411a4a5c8fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613034411a4a5c8fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2536594430","title":"Dianthus Therapeutics, Inc.2025财年第一财季实现净利润-29.51百万美元，同比减少114.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594430","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594430?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584051,"startTime":"0","endTime":"0","summary":"5月19日，Dianthus Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-29.51百万美元，同比减少114.62%；其中营业收入为1.16百万美元，同比增加32.72%，每股基本收益为-0.82美元。从资产负债表来看，Dianthus Therapeutics, Inc.总负债19.97百万美元，其中短期债务226000.00美元，资产负债比为0.18，流动比率为0.16。机构评级：截至2025年5月19日，当前有10家机构对Dianthus Therapeutics, Inc.目标价做出预测，其中目标均价为51.40美元，其中最低目标价为34.00美元，最高目标价为84.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000246a6e3a77d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000246a6e3a77d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DNTH"],"gpt_icon":0},{"id":"2535236315","title":"Dianthus Therapeutics, Inc.盘中异动 早盘快速上涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535236315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535236315?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:59","pubTimestamp":1747403975,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时59分，Dianthus Therapeutics, Inc.股票出现异动，股价快速上涨6.08%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215936a480fef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215936a480fef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","DNTH","BK4139","LENZ"],"gpt_icon":0},{"id":"2534454693","title":"Dianthus Therapeutics, Inc.盘中异动 下午盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534454693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534454693?lang=zh_cn&edition=full","pubTime":"2025-05-10 02:33","pubTimestamp":1746815598,"startTime":"0","endTime":"0","summary":"北京时间2025年05月10日02时33分，Dianthus Therapeutics, Inc.股票出现波动，股价大幅下跌5.29%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.83%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051002331994f20b7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051002331994f20b7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DNTH","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2533566879","title":"Dianthus Therapeutics, Inc.盘中异动 大幅下挫6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533566879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533566879?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:43","pubTimestamp":1746549831,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时43分，Dianthus Therapeutics, Inc.股票出现波动，股价大幅跳水6.45%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为5.17%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004351aa2c84cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004351aa2c84cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DNTH","LENZ","BK4007"],"gpt_icon":0},{"id":"2533875395","title":"Dianthus Therapeutics, Inc.盘中异动 快速跳水7.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533875395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533875395?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:31","pubTimestamp":1746451868,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时31分，Dianthus Therapeutics, Inc.股票出现波动，股价急速下挫7.33%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213108aa2c82d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213108aa2c82d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2527344397","title":"Dianthus Therapeutics, Inc.盘中异动 大幅拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527344397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527344397?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:12","pubTimestamp":1744726322,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时12分，Dianthus Therapeutics, Inc.股票出现异动，股价快速拉升5.18%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415221203a459d0ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415221203a459d0ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2527919051","title":"Dianthus Therapeutics, Inc.盘中异动 大幅上涨5.51%报18.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527919051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527919051?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:51","pubTimestamp":1744642276,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时51分，Dianthus Therapeutics, Inc.股票出现波动，股价急速拉升5.51%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.26%。其相关个股中，Third Harmonic Bio, Inc.、Theratechnologies Inc.、Metsera, Inc.涨幅较大，Artelo Biosciences, Inc.、Aditxt, Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为604.96%、316.17%、161.54%，振幅较大的相关个股有Artelo Biosciences, Inc.、Theratechnologies Inc.、Omniab Inc C/Wts ，振幅分别为48.91%、29.90%、25.22%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414225116a6ba2a70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414225116a6ba2a70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2517494669","title":"Dianthus Therapeutics, Inc.盘中异动 大幅拉升9.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517494669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517494669?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185055,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Dianthus Therapeutics, Inc.股票出现异动，股价急速拉升9.52%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223056abe9b05d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223056abe9b05d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","LENZ","BK4139"],"gpt_icon":0},{"id":"2516308756","title":"Dianthus Therapeutics, Inc.盘中异动 早盘快速下挫5.00%报20.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516308756?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:07","pubTimestamp":1741014460,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时07分，Dianthus Therapeutics, Inc.股票出现波动，股价大幅下跌5.00%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230741989a1a32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230741989a1a32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DNTH","LENZ"],"gpt_icon":0},{"id":"2514387469","title":"Dianthus Therapeutics, Inc.盘中异动 临近午盘大幅拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514387469?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:40","pubTimestamp":1740674403,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时40分，Dianthus Therapeutics, Inc.股票出现异动，股价大幅拉升5.19%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004003abdf8d22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004003abdf8d22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","BK4139","LENZ"],"gpt_icon":0},{"id":"2514566358","title":"Dianthus Therapeutics, Inc.盘中异动 早盘急速拉升7.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514566358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514566358?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580275,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，Dianthus Therapeutics, Inc.股票出现异动，股价快速拉升7.80%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223115abddec78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223115abddec78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DNTH","BK4139"],"gpt_icon":0},{"id":"2513778530","title":"Dianthus Therapeutics, Inc.盘中异动 早盘快速跳水5.85%报22.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778530?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:11","pubTimestamp":1740409876,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时11分，Dianthus Therapeutics, Inc.股票出现波动，股价急速跳水5.85%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231116a2521e62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231116a2521e62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DNTH"],"gpt_icon":0},{"id":"2512481862","title":"Dianthus Therapeutics, Inc.盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512481862?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:51","pubTimestamp":1739980266,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时51分，Dianthus Therapeutics, Inc.股票出现波动，股价快速跳水5.82%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235106abd50f87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235106abd50f87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DNTH","BK4139"],"gpt_icon":0},{"id":"2511815577","title":"Dianthus Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.00%报24.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511815577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511815577?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:00","pubTimestamp":1739480416,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日05时00分，Dianthus Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140500179884777e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140500179884777e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DNTH","LENZ"],"gpt_icon":0},{"id":"2509786830","title":"Dianthus Therapeutics, Inc.盘中异动 下午盘股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509786830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509786830?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:11","pubTimestamp":1738872676,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时11分，Dianthus Therapeutics, Inc.股票出现波动，股价快速下跌5.74%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207041116a23c1271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207041116a23c1271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DNTH"],"gpt_icon":0},{"id":"2509231487","title":"Dianthus Therapeutics, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509231487?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:09","pubTimestamp":1738775373,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时09分，Dianthus Therapeutics, Inc.股票出现波动，股价快速拉升5.34%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.89%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206010934abc39f80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206010934abc39f80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNTH","LENZ","BK4139"],"gpt_icon":0},{"id":"2507961840","title":"Dianthus Therapeutics, Inc.盘中异动 早盘大幅上涨5.03%报22.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507961840?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:04","pubTimestamp":1738335861,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时04分，Dianthus Therapeutics, Inc.股票出现异动，股价快速上涨5.03%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312304229614ef31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312304229614ef31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DNTH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.magentatx.com","stockEarnings":[{"period":"1week","weight":0.0642},{"period":"1month","weight":0.1071},{"period":"3month","weight":0.1391},{"period":"6month","weight":-0.1711},{"period":"1year","weight":-0.3076},{"period":"ytd","weight":-0.0798}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Dianthus Therapeutics, Inc.于2015年6月17日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，开发新药，为更多的患者带来骨髓移植的治疗能力。该公司打算成为移植医学领域的完全整合的发现，开发和商业公司。该公司相信产品组合将提供显著的商业协同效应。 该公司正在开发产品，以便可以单独使用或相互结合使用。因此，该公司的投资组合可以以适合患者疾病的方式使用，以便患者可以接受多于一种洋红疗法作为其个人移植旅程的一部分。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.1581},{"month":2,"riseRate":0.571429,"avgChangeRate":0.25232},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.018026},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.064022},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.056052},{"month":6,"riseRate":0.714286,"avgChangeRate":0.017401},{"month":7,"riseRate":0.625,"avgChangeRate":0.027007},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.033688},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.031616},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.091119},{"month":11,"riseRate":0.428571,"avgChangeRate":0.012009},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.17234}],"exchange":"NASDAQ","name":"Dianthus Therapeutics Inc.","nameEN":"Dianthus Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Dianthus Therapeutics Inc.(DNTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Dianthus Therapeutics Inc.(DNTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Dianthus Therapeutics Inc.,DNTH,Dianthus Therapeutics Inc.股票,Dianthus Therapeutics Inc.股票老虎,Dianthus Therapeutics Inc.股票老虎国际,Dianthus Therapeutics Inc.行情,Dianthus Therapeutics Inc.股票行情,Dianthus Therapeutics Inc.股价,Dianthus Therapeutics Inc.股市,Dianthus Therapeutics Inc.股票价格,Dianthus Therapeutics Inc.股票交易,Dianthus Therapeutics Inc.股票购买,Dianthus Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Dianthus Therapeutics Inc.(DNTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Dianthus Therapeutics Inc.(DNTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}